Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuaki Monde

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Journal of Virology|January 29, 2011
Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bisphosphateKazuaki Monde, Vineela Chukkapalli, Akira Ono
Biomolecules|March 28, 2024
Species-Specific Transcription Factors Associated with Long Terminal Repeat Promoters of Endogenous Retroviruses: A Comprehensive ReviewMd Jakir Hossain, Perpetual Nyame, Kazuaki Monde
Cellular Microbiology|January 16, 2007
A broad antiviral neutral glycolipid, fattiviracin FV-8, is a membrane fluidity modulatorShinji Harada, Kazumi Yokomizo, Kazuaki Monde, et al.
Biochemical and Biophysical Research Communications|March 2, 2005
Influence of membrane fluidity on human immunodeficiency virus type 1 entryShinji Harada, Keisuke Yusa, Kazuaki Monde, et al.
International Journal of Molecular Sciences|November 25, 2023
Interaction of TSG101 with the PTAP Motif in Distinct Locations of Gag Determines the Incorporation of HTLV-1 Env into the Retroviral VirionYosuke Maeda, Kazuaki Monde, Hiromi Terasawa, et al.
The Journal of Biological Chemistry|June 29, 2005
Isolation of TAK-779-resistant HIV-1 from an R5 HIV-1 GP120 V3 loop libraryKeisuke Yusa, Yosuke Maeda, Aki Fujioka, et al.
The Journal of Biological Chemistry|November 1, 2007
Gp120 V3-dependent impairment of R5 HIV-1 infectivity due to virion-incorporated CCR5Kazuaki Monde, Yosuke Maeda, Yuetsu Tanaka, et al.
Virology|March 29, 2011
A combination of polymorphic mutations in V3 loop of HIV-1 gp120 can confer noncompetitive resistance to maravirocYuzhe Yuan, Yosuke Maeda, Hiromi Terasawa, et al.
Virology|September 29, 2007
Neutralizing antibodies decrease the envelope fluidity of HIV-1Shinji Harada, Kazuaki Monde, Yuetsu Tanaka, et al.
Journal of Virology|August 3, 2012
Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1Kazuaki Monde, Rafael Contreras-Galindo, Mark H Kaplan, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Journal of Virology|January 29, 2011
Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bisphosphateKazuaki Monde, Vineela Chukkapalli, Akira Ono
Biomolecules|March 28, 2024
Species-Specific Transcription Factors Associated with Long Terminal Repeat Promoters of Endogenous Retroviruses: A Comprehensive ReviewMd Jakir Hossain, Perpetual Nyame, Kazuaki Monde
Cellular Microbiology|January 16, 2007
A broad antiviral neutral glycolipid, fattiviracin FV-8, is a membrane fluidity modulatorShinji Harada, Kazumi Yokomizo, Kazuaki Monde, et al.
Biochemical and Biophysical Research Communications|March 2, 2005
Influence of membrane fluidity on human immunodeficiency virus type 1 entryShinji Harada, Keisuke Yusa, Kazuaki Monde, et al.
International Journal of Molecular Sciences|November 25, 2023
Interaction of TSG101 with the PTAP Motif in Distinct Locations of Gag Determines the Incorporation of HTLV-1 Env into the Retroviral VirionYosuke Maeda, Kazuaki Monde, Hiromi Terasawa, et al.
The Journal of Biological Chemistry|June 29, 2005
Isolation of TAK-779-resistant HIV-1 from an R5 HIV-1 GP120 V3 loop libraryKeisuke Yusa, Yosuke Maeda, Aki Fujioka, et al.
The Journal of Biological Chemistry|November 1, 2007
Gp120 V3-dependent impairment of R5 HIV-1 infectivity due to virion-incorporated CCR5Kazuaki Monde, Yosuke Maeda, Yuetsu Tanaka, et al.
Virology|March 29, 2011
A combination of polymorphic mutations in V3 loop of HIV-1 gp120 can confer noncompetitive resistance to maravirocYuzhe Yuan, Yosuke Maeda, Hiromi Terasawa, et al.
Virology|September 29, 2007
Neutralizing antibodies decrease the envelope fluidity of HIV-1Shinji Harada, Kazuaki Monde, Yuetsu Tanaka, et al.
Journal of Virology|August 3, 2012
Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1Kazuaki Monde, Rafael Contreras-Galindo, Mark H Kaplan, et al.
Pageof 4